VegaVect, Inc.: Clinical Trials

1 trial sponsored by VegaVect, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow VegaVect, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis
RS1 AAV Vector - Retinoschisis, X-Linked
Phase 1 / Phase 2CompletedVegaVect, Inc.122015-02-112025-02-14

Conditions studied

Retinoschisis (1)

Countries

United States (1)

Top investigators

Laryssa A Huryn, M.D. (1)

Results publications

PMID 30196853, PMID 33601057, PMID 34390869, PMID 36227606